Edgewise Therapeutics, Inc. (EWTX) Tops Q1 EPS by 6c

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q1 EPS of ($0.33), $0.06 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

You May Also Be Interested In

• Edgewise Therapeutics (EWTX) PT Raised to $59; RBC Capital: 'We would be buyers on weakness'
• Pfizer reaffirms 2026 guidance after CFO transition news
• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance